Ligand validation:4PMY

XYP: beta-D-xylopyranose

XYP is a Ligand Of Interest in 4PMY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4PMY_XYP_A_401	99%	73%	0.051	0.979	0.49	0.57	-	-	0	0	100%	1
4PMY_XYP_B_401	93%	72%	0.064	0.959	0.54	0.55	-	-	0	0	100%	1
4PN2_XYP_B_403	88%	47%	0.065	0.958	0.6	1.43	-	2	0	0	90%	0.9
1OD8_XYP_A_1311	100%	64%	0.047	0.992	0.75	0.64	-	-	0	0	100%	1
1V0M_XYP_A_1304	100%	71%	0.035	0.993	0.82	0.33	-	-	0	0	90%	0.9
1V0N_XYP_A_1306	98%	60%	0.048	0.989	0.76	0.78	-	-	0	0	90%	0.9
1V0L_XYP_A_1305	98%	72%	0.055	0.992	0.52	0.57	-	-	0	0	90%	0.9
1FHD_XYP_A_601	96%	72%	0.042	0.97	0.68	0.41	-	-	0	0	90%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.